The Global Metamizole API Market was valued at USD 159 Million in 2025 and is projected to reach USD 144 Million by 2034, registering a Compound Annual Growth Rate (CAGR) of -1.6% during the forecast period (2026–2034). This market contraction is shaped by its restricted regulatory status in key markets like the US and parts of Europe due to safety concerns. However, persistent clinical demand in regions where it remains a cornerstone for severe pain and fever management continues to fuel a stable, albeit niche, global supply chain. In this blog, we profile the Top 10 Companies in the Metamizole API Industry—a mix of established chemical manufacturers and specialized pharmaceutical producers ensuring the reliable supply of this critical analgesic ingredient.

Download FREE Sample Report:
Metamizole API Market – View in Detailed Research Report

---

🔟 10. Chemcopia Ingredients Pvt Ltd

Headquarters: Hyderabad, India
Key Offering: Metamizole Sodium API (Analgin), High-Purity Grades

Chemcopia Ingredients is a specialized Indian API manufacturer focusing on a portfolio of niche pharmaceutical ingredients, including Metamizole. The company serves both domestic formulators and international clients, leveraging India’s cost-effective manufacturing base. Their operations emphasize compliance with pharmacopoeial standards to meet the requirements of markets where the drug is legally permissible.

Strategic Focus:

• Supply of APIs to generic pharmaceutical companies
• Focus on stringent quality control for impurity profiles
• Expanding reach in permissible Asian and Latin American markets

---

9️⃣ 9. Hachidai Pharmaceutical Co Ltd

Headquarters: Osaka, Japan
Key Offering: Metamizole Sodium (Analgin) API for Regional Markets

Hachidai Pharmaceutical operates as a key regional supplier within Japan and select Asian markets. While metamizole use in Japan is highly restricted, the company’s expertise in chemical synthesis allows it to supply API for specific authorized applications and for export to countries where its use is approved, demonstrating adaptability within a complex regulatory landscape.

Strategic Focus:

• Supply for limited domestic therapeutic use and veterinary applications
• Export-oriented API manufacturing
• High-standard GMP manufacturing facilities

---

8️⃣ 8. Vani Pharma Labs Limited

Headquarters: Hyderabad, India
Key Offering: Metamizole Sodium API, Custom Synthesis

Vani Pharma Labs is an emerging Indian player in the API space, producing Metamizole for the formulation sector. The company focuses on competitive pricing and reliable supply to tap into the steady demand from Indian and neighboring countries’ pharmaceutical manufacturers who produce a range of finished dosage forms.

Strategic Focus:

• Cost-competitive production for volume-driven markets
• Building long-term supply agreements with formulators
• Adherence to international quality testing protocols

---

7️⃣ 7. Haisen Pharma

Headquarters: Shandong, China
Key Offering: High-Purity Metamizole Sodium API

Haisen Pharma is part of China’s vast pharmaceutical chemical manufacturing ecosystem. The company produces Metamizole API, contributing significantly to the country’s export volume. Their operations benefit from integrated supply chains for raw materials, enabling stable production to serve global markets where demand persists.

Strategic Focus:

• Large-scale chemical synthesis and production
• Serving global distributors and formulation houses
• Focus on process efficiency to maintain margin in a competitive market

---

6️⃣ 6. Huadong Medicine (Xi’an) Bohua Pharmaceutical Co., Ltd.

Headquarters: Xi’an, Shaanxi, China
Key Offering: Analgin (Metamizole Sodium) API

As part of the larger Huadong Medicine Group, Bohua Pharmaceutical leverages significant R&D and manufacturing resources. The company produces Metamizole API, ensuring high purity levels suitable for injectable formulations, which are critical for hospital use in many countries.

Strategic Focus:

• Production aligned with pharmacopoeial standards (e.g., EP, USP where applicable)
• Supply chain integration for key starting materials
• Catering to the specific needs of injection manufacturers

Download FREE Sample Report:
Metamizole API Market – View in Detailed Research Report

---

5️⃣ 5. Jiheng Pharmaceutical Co., Ltd

Headquarters: Shandong, China
Key Offering: Metamizole Sodium (≥99% Purity), Pharmaceutical Intermediates

Jiheng Pharmaceutical is a major Chinese manufacturer with a strong export orientation for Metamizole API. The company’s scale allows it to compete effectively on price and volume, making it a preferred supplier for many international buyers sourcing API for markets in Latin America, Eastern Europe, and Asia.

Strategic Focus:

• Economies of scale in production
• Robust international sales and distribution network
• Consistent focus on the high-purity (≥99%) segment

---

4️⃣ 4. Wuyao Pharmaceutical Co., Ltd

Headquarters: Hubei, China
Key Offering: Metamizole Sodium API, Custom Manufacturing

Wuyao Pharmaceutical is a significant and established producer of Metamizole API, known for its reliable supply and consistent quality. The company’s manufacturing processes are optimized to handle the multi-step synthesis required, ensuring it remains a key node in the global supply chain for this molecule.

Strategic Focus:

• Long-standing expertise in Metamizole synthesis
• Supply agreements with leading generic pharmaceutical companies
• Investment in impurity control and process validation

---

3️⃣ 3. Hachidai Pharmaceutical (Reiterated for Regional Leadership)

Headquarters: Osaka, Japan
Key Offering: High-Quality Metamizole API for Regulated Markets

Hachidai’s position is noteworthy due to its operation from Japan, a market with stringent quality expectations. This allows the company to produce API that meets high regulatory standards, making its product desirable for formulators in regulated markets where Metamizole is still permitted, such as certain European countries, seeking assured quality.

Strategic Focus:

• Leveraging Japanese manufacturing quality prestige
• Targeting premium, quality-sensitive market segments
• Navigating complex export regulations for controlled substances

---

2️⃣ 2. Moehs Group

Headquarters: Barcelona, Spain
Key Offering: Metamizole Sodium API, Focus on European and Ibero-American Markets

The Moehs Group stands as a critical European supplier of Metamizole API. With deep regulatory expertise and GMP-compliant facilities in Spain, the company is a pivotal source for pharmaceutical manufacturers within Europe (e.g., Germany, Spain) and Latin America where the drug is widely used. Their proximity and understanding of these key markets provide a significant strategic advantage.

Strategic Focus:

• Strategic supplier for European and Latin American formulators
• Deep compliance with EMA and other regional regulations
• Strong technical support and supply reliability for clients

---

1️⃣ 1. Xinhua Pharmaceutical Company Limited

Headquarters: Shandong, China
Key Offering: Metamizole Sodium API, Full Chemical Synthesis Portfolio

Xinhua Pharmaceutical is arguably the global volume leader in Metamizole API production. As a large, publicly-listed Chinese pharmaceutical enterprise, it boasts extensive chemical manufacturing infrastructure and vertical integration. This scale allows it to dominate the supply landscape, providing the bulk of API that feeds formulation lines across the permissible markets worldwide.

Strategic Focus:

• Unmatched production scale and cost leadership
• Control over the upstream chemical supply chain
• Global distribution reach, serving as a primary source for international distributors

Get Full Report Here:
Metamizole API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of the Metamizole API Market is Consolidation and Quality Focus

The Metamizole API market is navigating a phase of mature stabilization. While global value is contracting, the market is defined by irreplaceable demand in specific therapeutic settings across key regions. The future will be shaped by manufacturers’ ability to operate efficiently within a strict regulatory framework and evolving competitive pressures.

📈 Key Trends Shaping the Market:

• Consolidation of supply among top-tier, cost-effective manufacturers in Asia
• Increasing emphasis on high-purity (≥99%) API grades, especially for injectable formulations
• Process innovation for higher yield and better impurity control to ensure safety
• Strategic regional partnerships, with European players like Moehs servicing regulated niches

Get Full Report Here:
Metamizole API Market – View in Detailed Research Report

The companies listed above are not only supplying a critical analgesic ingredient—they’re sustaining access to an essential medicine for millions in markets where its benefit-risk profile remains accepted within national healthcare systems.